WhichRecall
Class IIReported 2025-08-20

Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpack and Print Mat Labels), 0006-0033-30 (Carton Label)

Recalled by Merck & Co. Inc

Reason for Recall

Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.

Advertisement
Recall Number
D-0584-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-07-21
Reported
2025-08-20
Distribution
Nationwide in the USA and PR.
Code Info
Lots 2090019 and 2123744, Exp. 4/30/2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement